Adrià López‐Fernández

933 total citations
18 papers, 199 citations indexed

About

Adrià López‐Fernández is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Adrià López‐Fernández has authored 18 papers receiving a total of 199 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 9 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Adrià López‐Fernández's work include BRCA gene mutations in cancer (12 papers), Genomics and Rare Diseases (5 papers) and DNA Repair Mechanisms (5 papers). Adrià López‐Fernández is often cited by papers focused on BRCA gene mutations in cancer (12 papers), Genomics and Rare Diseases (5 papers) and DNA Repair Mechanisms (5 papers). Adrià López‐Fernández collaborates with scholars based in Spain, Palestinian Territory and Sweden. Adrià López‐Fernández's co-authors include Judith Balmañà, Orland Dı́ez, Sara Gutiérrez‐Enríquez, Gemma Montalban, Alejandro Moles‐Fernández, Sandra Bonache, Estela Carrasco, Neda Stjepanovic, Vanessa Bach and Conxi Lázaro and has published in prestigious journals such as International Journal of Cancer, European Urology and Journal of Medical Genetics.

In The Last Decade

Adrià López‐Fernández

16 papers receiving 199 citations

Peers

Adrià López‐Fernández

GENET

PFM

ONCOL

Mónica Salinas Spain

Paula Rofes Spain

Olga Campos Spain

Gillian Mitchell Australia

Ana Blatnik Slovenia

Wendy A. van Zelst-Stams Netherlands

Sami Belhadj Spain

Bartłomiej Gliniewicz Poland

Lily Hoang United States

Giovanna De Vecchi Italy

Mónica Salinas Spain

Adrià López‐Fernández

87 ×0.8

GENET

85 ×0.8

51 ×1.0

PFM

41 ×0.9

37 ×1.1

ONCOL

Citations per year, relative to Adrià López‐Fernández Adrià López‐Fernández (= 1×) peers Mónica Salinas

Countries citing papers authored by Adrià López‐Fernández

Since Specialization

Citations

This map shows the geographic impact of Adrià López‐Fernández's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrià López‐Fernández with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrià López‐Fernández more than expected).

Fields of papers citing papers by Adrià López‐Fernández

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrià López‐Fernández. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrià López‐Fernández. The network helps show where Adrià López‐Fernández may publish in the future.

Co-authorship network of co-authors of Adrià López‐Fernández

This figure shows the co-authorship network connecting the top 25 collaborators of Adrià López‐Fernández. A scholar is included among the top collaborators of Adrià López‐Fernández based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrià López‐Fernández. Adrià López‐Fernández is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Papakonstantinou, Andri, Adrià López‐Fernández, Judit Matito, et al.. (2025). Identifying germline pathogenic variants in breast cancer using tumor sequencing. The Breast. 81. 104439–104439. 1 indexed citations

López‐Fernández, Adrià, et al.. (2025). Exploring communication preferences for disclosing breast cancer risk in women with a family history. Journal of Genetic Counseling. 34(5). e70114–e70114.

Castillejo, Adela, Mercedes Robledo, Àlex Teulé, et al.. (2024). Genetic and clinical characterization of a novel FH founder mutation in families with hereditary leiomyomatosis and renal cell cancer syndrome. Orphanet Journal of Rare Diseases. 19(1). 26–26. 1 indexed citations

López‐Fernández, Adrià, Guillermo Villacampa, Mónica Salinas, et al.. (2023). Role of psychological background in cancer susceptibility genetic testing distress: It is not only about a positive result. Journal of Genetic Counseling. 32(4). 778–787. 3 indexed citations

López‐Fernández, Adrià, et al.. (2022). A case of Rothmund-Thomson syndrome originally thought to be a case of Bloom syndrome. Familial Cancer. 22(1). 99–102.

Carrasco, Estela, Adrià López‐Fernández, Marta Codina‐Solà, et al.. (2022). Clinical and psychological implications of secondary and incidental findings in cancer susceptibility genes after exome sequencing in patients with rare disorders. Journal of Medical Genetics. 60(7). 685–691. 6 indexed citations

Montalban, Gemma, Sandra Bonache, Vanessa Bach, et al.. (2021). BRCA1 and BRCA2 whole cDNA analysis in unsolved hereditary breast/ovarian cancer patients. Cancer Genetics. 258-259. 10–17. 5 indexed citations

López‐Fernández, Adrià, Guillermo Villacampa, Èlia Grau, et al.. (2021). Patients’ and professionals’ perspective of non-in-person visits in hereditary cancer: predictors and impact of the COVID-19 pandemic. Genetics in Medicine. 23(8). 1450–1457. 4 indexed citations

López‐Fernández, Adrià, Clara Serra‐Juhé, Judith Balmañà, & Eduardo F. Tizzano. (2020). Integración del asesor genético en el modelo asistencial multidisciplinar en genética clínica y cáncer hereditario. Medicina Clínica. 155(2). 77–81. 1 indexed citations

10.

López‐Fernández, Adrià, Clara Serra‐Juhé, Judith Balmañà, & Eduardo F. Tizzano. (2020). Genetic counsellors in a multidisciplinary model of clinical genetics and hereditary cancer. Medicina Clínica (English Edition). 155(2). 77–81. 3 indexed citations

11.

Feliubadaló, Lídia, Adrià López‐Fernández, Marta Pineda, et al.. (2019). Opportunistic testing of BRCA1, BRCA2 and mismatch repair genes improves the yield of phenotype driven hereditary cancer gene panels. International Journal of Cancer. 145(10). 2682–2691. 30 indexed citations

12.

López‐Fernández, Adrià, et al.. (2018). A narrative overview of the patients’ outcomes after multigene cancer panel testing, and a thorough evaluation of its implications for genetic counselling. European Journal of Medical Genetics. 62(5). 342–349. 6 indexed citations

13.

Bonache, Sandra, Alejandro Moles‐Fernández, Gemma Montalban, et al.. (2018). Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings. Journal of Cancer Research and Clinical Oncology. 144(12). 2495–2513. 49 indexed citations

14.

Moles‐Fernández, Alejandro, Gemma Montalban, Sandra Bonache, et al.. (2018). Computational Tools for Splicing Defect Prediction in Breast/Ovarian Cancer Genes: How Efficient Are They at Predicting RNA Alterations?. Frontiers in Genetics. 9. 366–366. 46 indexed citations

15.

Montalban, Gemma, Sandra Bonache, Alejandro Moles‐Fernández, et al.. (2018). Alternative transcript imbalance underlying breast cancer susceptibility in a family carrying PALB2 c.3201+5G>T. Breast Cancer Research and Treatment. 174(2). 543–550. 4 indexed citations

16.

Montalban, Gemma, Irene López‐Perolio, Pedro Pérez‐Segura, et al.. (2018). Characterization of spliceogenic variants located in regions linked to high levels of alternative splicing:BRCA2c.7976+5G > T as a case study. Human Mutation. 39(9). 1155–1160. 10 indexed citations

17.

Montalban, Gemma, Sandra Bonache, Alejandro Moles‐Fernández, et al.. (2018). Screening of BRCA1/2 deep intronic regions by targeted gene sequencing identifies the first germline BRCA1 variant causing pseudoexon activation in a patient with breast/ovarian cancer. Journal of Medical Genetics. 56(2). 63–74. 24 indexed citations

18.

López‐Fernández, Adrià, et al.. (1998). Urinary N-Acetyl-β-N- Glucosaminidase in Patientswith Urinary Tract Infection. European Urology. 33(3). 348–350. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact